Trump Announces Plan for 100% Tariffs on Generic Drugs Starting in 2028
2026/08/17 | Pharmaceutical Technology
In Historic Decision, China Issues World-First Approval for Narcolepsy Therapy
2026/08/17 | China Daily
Survey Finds More Pharma Executives Expect HEOR Input on Clinical Trial Design
2026/08/17 | Tufts Medical Center
Oxford Vaccine Group Launches Bundibugyo Ebolavirus Vaccine Trial
2026/08/17 | University of Oxford
CMS Proposes Reforms for More Meaningful Value-Based Care Pathways
2026/08/17 | CMS.gov
Review of 10 HTA Systems Highlights Importance of Institutional Design
2026/08/17 | Centre for Innovation in Regulatory Science
15-Minute Whole-Blood Test Could Improve Triaging for Suspected Brain Injury
2026/08/17 | Lancet Regional Health Americas
United Nations Agencies Collaborate on Framework for AI in Health Innovations
2026/08/17 | Health Policy Watch
Latin American Study Supports Lifestyle Intervention for Cognitive Function
2026/08/17 | The Lancet
Retinal Prosthesis for Age-Related Macular Degeneration Launches in Germany
2026/08/17 | Science Corp.
Insurance Denials for Brand-Name Drugs Rose Sharply from 2018 to 2024
2026/08/17 | Johns Hopkins University
Malaria Chemoprevention for Children Could Yield Billions in Societal Benefits
2026/08/17 | Liverpool School of Tropical Medicine
WHO Report Predicts 67% Increase in Global Cancer Cases by 2050
2026/08/17 | Health Policy Watch
US and Tanzania Sign Health Cooperation Memorandum of Understanding
2026/08/17 | UA Embassy in Tanzania
McKinsey Report Says BioPharma Needs R&D Redesign to Maximize AI’s Impact
2026/08/17 | BioSpace
Cost Modeling With Real-World Data Favors 8 mg Aflibercept Regimens
2026/08/17 | Journal of VitreoRetinal Diseases
Atrial Fibrillation Consortium Identifies Patient-Centric Surrogate Endpoint
2026/08/17 | American Heart Journal
Australia Reflects on First Year of National Lung Cancer Screening Program
2026/08/17 | Lung Foundation Australia
Subscribe to the HEOR News Desk
SubscribeAlready have an ISPOR Profile? Click here to manage your subscriptions.